BIBLIOGRAPHIC RECORD
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Anastasia S. Suraev; Ronald R. Grunstein; Nathaniel S. Marshall; Angela L. D'Rozario; Christopher James Gordon; Delwyn J. Bartlett; KEITH K. H. WONG; Brendon John Yee; Ryan G. Vandrey; Christopher G. Irwin; Jonathon Carl Arnold; Iain S. McGregor; Camilla M. Hoyos
- Source of metadata
- OpenAlex
- Year recorded
- 2020
Public identifiers and source
Open the source recordReference
Anastasia S. Suraev; Ronald R. Grunstein; Nathaniel S. Marshall; Angela L. D'Rozario; Christopher James Gordon; Delwyn J. Bartlett; KEITH K. H. WONG; Brendon John Yee; Ryan G. Vandrey; Christopher G. Irwin; Jonathon Carl Arnold; Iain S. McGregor; Camilla M. Hoyos. (2020). Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. https://openalex.org/W3027745507
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-1da4d59fd320237de78c61dd6de542e5/